Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Medical technology. --- Clinical medicine. --- Medical innovations. --- Innovations, Medical --- Medicine --- Medical technology --- Technological innovations --- Health care technology --- Health technology --- Technology --- Medicine, Clinical --- Innovations --- Tecnologia mèdica --- Medicina clínica
Choose an application
Medicine itself is sick. We hardly understand any disease and therefore need to chronically treat symptoms but not the causes. Consequently, drugs and other therapies help only very few patients; yet we are pumping more and more money into our healthcare system without any added value and neglect prevention. Thus, the internationally renowned physician scientist, Harald H.H.W. Schmidt, MD, PhD, PharmD, professor at Maastricht University, predicts the end of medicine as we know it. On a positive note, digitization will radically change healthcare and lead to one of the greatest socioeconomic revolutions of mankind. He is one of the pioneers of "systems medicine", a complete redefinition of what we call a "disease", how we organize medicine and how we use Big Data to heal rather than treat, and to prevent rather than cure. In this book the author first proves the deep crisis of medicine, and then also describes how medicine will become more precise, more preventive, safer and, surprisingly, more affordable. "Dr. Harald Schmidt convincingly explains the limitations in the current practice of medicine and the need for big data and a systems approach." Ferid Murad MD, PhD, Nobel Laureate in Medicine 1998 "Visionary, provocative, and full of insights. Professor Schmidt gives a unique and authoritative perspective to the past, present and future of medical science and clinical practice. And all presented in such an inimitable style." Prof. Robert F. W. Moulds, MBBS PhD FRACP, Former Dean Royal Melbourne Hospital Clinical School of the University of Melbourne, Australia The translation was performed with the help of artificial intelligence (machine translation by the service DeepL.com). Subsequent human revision including updating of each chapter was carried out mainly with a view to internationalization of the content, so that the book reads differently from a simple translation in terms of style and timeliness.
Economics --- Biology --- Hygiene. Public health. Protection --- Pharmacology. Therapy --- Pathological biochemistry --- Human medicine --- volksgezondheid --- medische biochemie --- farmacologie --- biologie --- biomedische wetenschappen --- economie --- geneeskunde --- gezondheidszorg --- gezondheidseconomie
Choose an application
Reactive oxygen species (ROS) have been implicated in almost every human disease phenotype, without much, if any, therapeutic consequence foremost exemplified by the failure of the so-called anti-oxidants. This book is a game changer for the field and many clinical areas such as cardiology and neurology. The term ‘oxidative stress’ is abandoned and replaced with a systems medicine and network pharmacology-based mechanistic approach to disease. The ROS-related drugs discussed here target either ROS- forming or ROS -modifying enzymes for which there is strong clinical evidence. In addition, ROS targets are included as they jointly participate in causal mechanisms of disease. This approach is transforming the ROS field and represents a breakthrough in redox medicine indicating a path to patient benefit. In the coming years more targets and drugs may be discovered, but the approach will remain the same and this book will thus become, and for many years remain, the leading reference for ROSopathies and their treatment by network pharmacology. Chapter "Soluble Guanylate Cyclase Stimulators and Activators" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
Cardiology. --- Neurosciences. --- Neural sciences --- Neurological sciences --- Neuroscience --- Medical sciences --- Nervous system --- Heart --- Internal medicine --- Diseases --- Oxigen actiu --- Ús terapèutic --- Farmacologia --- Pharmacology. --- Clinical biochemistry. --- Neuroscience. --- Medical Biochemistry. --- Medicina --- Biofarmàcia --- Biotransformació (Metabolisme) --- Dermofarmacologia --- Desenvolupament de medicaments --- Estabilitat dels medicaments --- Farmacocinètica --- Farmacogenètica --- Farmacologia cardiovascular --- Farmacologia clínica --- Farmacologia dental --- Farmacologia geriàtrica --- Farmacologia molecular --- Farmacologia obstètrica --- Farmacologia ocular --- Farmacologia pediàtrica --- Farmacologia respiratòria --- Farmacologia renal --- Farmacologia veterinària --- Fotofarmacologia --- Immunofarmacologia --- Isòtops radioactius en farmacologia --- Neurofarmacologia --- Psicofarmacologia --- Química farmacèutica --- Radiofàrmacs --- Resistència als medicaments --- Toxicologia --- Medicaments --- Quimioteràpia --- Aplicacions mèdiques --- Aplicacions terapèutiques --- Ús en medecina --- Medicina alternativa --- Terapèutica --- Anions superòxid --- Oxigen reactiu --- Radicals d'oxigen --- Oxigen --- Medical biochemistry --- Pathobiochemistry --- Pathological biochemistry --- Biochemistry --- Pathology --- Drug effects --- Medical pharmacology --- Chemicals --- Chemotherapy --- Drugs --- Pharmacy --- Physiological effect
Choose an application
Reactive oxygen species (ROS) have been implicated in almost every human disease phenotype, without much, if any, therapeutic consequence foremost exemplified by the failure of the so-called anti-oxidants. This book is a game changer for the field and many clinical areas such as cardiology and neurology. The term 'oxidative stress' is abandoned and replaced with a systems medicine and network pharmacology-based mechanistic approach to disease. The ROS-related drugs discussed here target either ROS- forming or ROS -modifying enzymes for which there is strong clinical evidence. In addition, ROS targets are included as they jointly participate in causal mechanisms of disease. This approach is transforming the ROS field and represents a breakthrough in redox medicine indicating a path to patient benefit. In the coming years more targets and drugs may be discovered, but the approach will remain the same and this book will thus become, and for many years remain, the leading reference for ROSopathies and their treatment by network pharmacology. Chapter "Soluble Guanylate Cyclase Stimulators and Activators" is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
History of human medicine --- Human biochemistry --- Pathological biochemistry --- Pathology of the circulatory system --- Neuropathology --- neurologie --- farmacologie --- biochemie --- cardiologie
Choose an application
After the discovery of endogenous NO formation in the late '80s and the 1998 Nobel Prize in Physiology or Medicine, many researchers and physicians again became interested in the NO/sGC interaction and cGMP-dependent signaling. This book is an enthusiastic celebration of cyclic guanosine monophosphate (cGMP) and amply illustrates the importance of this field of science to patients and the way in which the field has evolved. It is exclusively devoted to this exciting and important signaling molecule, addressing all recent advances in understanding guanylate cyclase regulation, NO/sGC interactions, cGMP effector mechanisms and their pathophysiological and pharmacological implications. Particular attention will also be given to clinical applications of the novel cGMP-elevating drugs which are on the horizon, thus spanning the continuum from basic science to clinic.
Biochemistry. --- Cyclic adenylic acid. --- Cyclic GMP. --- Cyclic guanylic acid. --- Medicine. --- Protein kinase --Metabolism --Collected works. --- Protein kinases. --- Nucleotides, Cyclic --- Guanine Nucleotides --- Purine Nucleotides --- Ribonucleotides --- Nucleotides --- Nucleic Acids, Nucleotides, and Nucleosides --- Purines --- Chemicals and Drugs --- Heterocyclic Compounds, 2-Ring --- Heterocyclic Compounds --- Cyclic GMP --- Health & Biological Sciences --- Human Anatomy & Physiology --- Pharmacy, Therapeutics, & Pharmacology --- Animal Biochemistry --- Cyclic nucleotides. --- cGMP (Biochemical) --- Cyclic guanosine monophosphate --- Guanosine cyclic monophosphate --- Guanylic acid, Cyclic --- Life sciences. --- Human physiology. --- Molecular biology. --- Pharmacology. --- Medical biochemistry. --- Life Sciences. --- Biochemistry, general. --- Pharmacology/Toxicology. --- Medical Biochemistry. --- Human Physiology. --- Molecular Medicine. --- Cyclic nucleotides --- Toxicology. --- Clinical sciences --- Medical profession --- Human biology --- Life sciences --- Medical sciences --- Pathology --- Physicians --- Physiology --- Human body --- Chemicals --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Biological chemistry --- Chemical composition of organisms --- Organisms --- Physiological chemistry --- Biology --- Chemistry --- Toxicology --- Composition --- Health Workforce --- Pharmacologies --- Pharmaceutical Preparations --- pharmacology --- Molecular biochemistry --- Molecular biophysics --- Biochemistry --- Biophysics --- Biomolecules --- Systems biology --- Medical biochemistry --- Pathobiochemistry --- Pathological biochemistry --- Drug effects --- Medical pharmacology --- Chemotherapy --- Drugs --- Pharmacy --- Physiological effect
Choose an application
After the discovery of endogenous NO formation in the late '80s and the 1998 Nobel Prize in Physiology or Medicine, many researchers and physicians again became interested in the NO/sGC interaction and cGMP-dependent signaling. This book is an enthusiastic celebration of cyclic guanosine monophosphate (cGMP) and amply illustrates the importance of this field of science to patients and the way in which the field has evolved. It is exclusively devoted to this exciting and important signaling molecule, addressing all recent advances in understanding guanylate cyclase regulation, NO/sGC interactions, cGMP effector mechanisms and their pathophysiological and pharmacological implications. Particular attention will also be given to clinical applications of the novel cGMP-elevating drugs which are on the horizon, thus spanning the continuum from basic science to clinic.
Molecular biology --- Human biochemistry --- Human physiology --- Pharmacology. Therapy --- Pathological biochemistry --- farmacie --- farmacologie --- biochemie --- toxicologie --- fysiologie --- moleculaire biologie
Choose an application
History of human medicine --- Human biochemistry --- Pathological biochemistry --- Pathology of the circulatory system --- Neuropathology --- neurologie --- farmacologie --- biochemie --- cardiologie
Choose an application
Molecular biology --- Human biochemistry --- Human physiology --- Pharmacology. Therapy --- Pathological biochemistry --- farmacie --- farmacologie --- biochemie --- toxicologie --- fysiologie --- moleculaire biologie
Listing 1 - 8 of 8 |
Sort by
|